Trial intelligence / Profile preview

Rosuvastatin for Inflammation in Cardiac Valve Surgery

NCT01425398Phase 3Completed

Sponsor
McGill University Health Centre
Start
Nov 2011
Primary completion
Dec 2013
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of rosuvastatin in post-operative inflammation, sponsored by McGill University Health Centre. Started Nov 2011; status: completed.

02

Drugs

rosuvastatin
03

Conditions

post-operative inflammation

Beyond the preview

Go deeper on NCT01425398.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01425398.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call